bortezomib
Drug Details
- Generic Name
- bortezomib
- Brand Names
- Bortezomib, VELCADE, bortezomib, BORTEZOMIB
- Application Number
- ANDA208392
- Sponsor
- Pharmascience Inc.
- NDC Codes
- 10
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER, INJECTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- BORTEZOMIB
Indications and Usage
1 INDICATIONS AND USAGE BORUZU is a proteasome inhibitor indicated for: treatment of adult patients with multiple myeloma ( 1.1 ) treatment of adult patients with mantle cell lymphoma ( 1.2 ) 1.1 Multiple Myeloma BORUZU is indicated for the treatment of adult patients with multiple myeloma. 1.2 Mantle Cell Lymphoma BORUZU is indicated for the treatment of adult patients with mantle cell lymphoma.